期刊
EMBO MOLECULAR MEDICINE
卷 14, 期 9, 页码 -出版社
WILEY
DOI: 10.15252/emmm.202215855
关键词
drug resistance; FBXW7; GCN2; ISR; mitochondria
资金
- Spanish Ministry of Science, Innovation, and Universities [RTI2018-102204-B-I00]
- European FEDER funds
- Spanish Association Against Cancer (AECC) [PROYE20101FERN]
- Spanish Ministry of Science, Innovation and Universities [RTI2018-097596-B-I00]
- La Caixa Foundation
- Marie Sklodowska-Curie European Union [LCF/BQ/IN17/11620001]
- MCI/FEDER, UE
Deficiency of FBXW7 leads to multidrug resistance and sensitivity to drugs activating the integrated stress response (ISR). Targeting mitochondrial translation can activate ISR, which provides a new strategy for treating FBXW7-deficient tumors.
FBXW7 is one of the most frequently mutated tumor suppressors, deficiency of which has been associated with resistance to some anticancer therapies. Through bioinformatics and genome-wide CRISPR screens, we here reveal that FBXW7 deficiency leads to multidrug resistance (MDR). Proteomic analyses found an upregulation of mitochondrial factors as a hallmark of FBXW7 deficiency, which has been previously linked to chemotherapy resistance. Despite this increased expression of mitochondrial factors, functional analyses revealed that mitochondria are under stress, and genetic or chemical targeting of mitochondria is preferentially toxic for FBXW7-deficient cells. Mechanistically, the toxicity of therapies targeting mitochondrial translation such as the antibiotic tigecycline relates to the activation of the integrated stress response (ISR) in a GCN2 kinase-dependent manner. Furthermore, the discovery of additional drugs that are toxic for FBXW7-deficient cells showed that all of them unexpectedly activate a GCN2-dependent ISR regardless of their accepted mechanism of action. Our study reveals that while one of the most frequent mutations in cancer reduces the sensitivity to the vast majority of available therapies, it renders cells vulnerable to ISR-activating drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据